Letters to the Editor

CCND2 mutations are infrequent events in BCR-ABL1 negative myeloproliferative neoplasm patients

APHP, Laboratoire de Biologie Cellulaire, Hopital Saint-Louis, Paris, France;
APHP, Laboratoire de Biologie Cellulaire, Hopital Saint-Louis, Paris, France;
APHP, Laboratoire de Biologie Cellulaire, Hopital Saint-Louis, Paris, France;
APHP, Centre d'Investigations Cliniques, Hopital Saint-Louis, Paris, France;
Université de Paris-Saclay, INSERM UMR1287, Institut Gustave Roussy, Villejuif, France
APHP, Laboratoire de Biologie Cellulaire, Hopital Saint-Louis, Paris, France;
APHP, Centre d'Investigations Cliniques, Hopital Saint-Louis, Paris, France;
Haematologica Early view May 15, 2020 https://doi.org/10.3324/haematol.2020.252643